Comments on Proposed Rule Regarding Approach to PFAS Reporting Requirements and Supplier Notification for Chemicals of Special Concern Share page: Docket Number: EPA–HQ–TRI–2022–0270 Download Document Issues: OTC Medicines Dietary Supplements Consumer Medical Devices Other Issues Packaging Sustainability PFAS Related Posts Press Releases and Statements West Virginia Expands Access to OTC Cold & Allergy Medications Containing PSE Mar 6, 2024 Press Releases and Statements CHPA Statement on Valisure Citizen Petition Mar 6, 2024 Summary of State Sales Tax Jun 1, 2018